(Q37777899)

23 August 2017

0 references

1 reference

title

Improving the translational hit of experimental treatments in multiple sclerosis (English)

1 reference

23 August 2017

0 references

Emily S Sena

2

0 references

Malcolm Macleod

object named as

Malcolm R Macleod

6

0 references

Anna Williams

object named as

Anna Williams

4

0 references

Hanna M Vesterinen

1

object named as

Hanna M Vesterinen

1 reference

23 August 2017

5

Siddharthan Chandran

1 reference

23 August 2017

Charles ffrench-Constant

3

1 reference

23 August 2017

4 August 2010

1 reference

Multiple Sclerosis Journal

23 August 2017

1 reference

23 August 2017

16

1 reference

23 August 2017

9

1 reference

23 August 2017

1044-1055

1 reference

Immunomodulatory drugs for multiple sclerosis: a systematic review of clinical and cost effectiveness

23 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F1352458510379612

Natalizumab: bound to rebound?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510379612

Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510379612

Systematic review and meta-analysis of the efficacy of tirilazad in experimental stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510379612

Systematic review and metaanalysis of the efficacy of FK506 in experimental stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510379612

Comparison of treatment effects between animal experiments and clinical trials: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510379612

Reprint: Good laboratory practice: preventing introduction of bias at the bench

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510379612

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510379612

Axonal damage is reduced following glatiramer acetate treatment in C57/bl mice with chronic-induced experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510379612

Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510379612

Publication bias in clinical trials due to statistical significance or direction of trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510379612

Lost in translation: treatment trials in the SOD1 mouse and in human ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510379612

How can we improve the pre-clinical development of drugs for stroke?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510379612

21 January 2018

Identifiers

DOI

10.1177/1352458510379612

1 reference

23 August 2017

1 reference

PubMed ID

20685763